Metraipolis › archive › dc_4bc5fe6726c8

Multi-gradient permutation survival analysis identifies mitosis and immune signatures steadily associated with cancer patient prognosis — Europe PMC PMID:41404730

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41404730
DOI
10.7554/elife.101619
License (as archived)
solo-consultazione
Archived
2026-10-10T00:45:22.564Z
SHA-256 of the archived text
ff5841a6587983754fcf00417faa85d9db850863348e08a24bbae67ef2ba7137
Stable URL of this page
https://metraipolis.com/documento/dc_4bc5fe6726c8

How to cite

Multi-gradient permutation survival analysis identifies mitosis and immune signatures steadily associated with cancer patient prognosis — Europe PMC PMID:41404730 — Europe PMC (en), https://europepmc.org/article/MED/41404730 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4bc5fe6726c8 (Metraipolis archive dc_4bc5fe6726c8, sha256 ff5841a6587983754fcf00417faa85d9db850863348e08a24bbae67ef2ba7137)
BibTeX
@misc{dc4bc5fe6726c8,
  title = {Multi-gradient permutation survival analysis identifies mitosis and immune signatures steadily associated with cancer patient prognosis — Europe PMC PMID:41404730},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41404730},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4bc5fe6726c8; sha256 ff5841a6587983754fcf00417faa85d9db850863348e08a24bbae67ef2ba7137},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41404730. Agents can read the archived copy with the MCP tool read_document.